Please login to the form below
durvulamab
This page shows the latest durvulamab news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca shaken by FDA partial hold on durvalumab trial
Aims to resume trial recruitment as soon as possible after bleeding side effects curb study
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Account Director - Digital
-
Great salary and benefits
-
Scientific Team Lead
-
Competitive Salary
-
Associate Medical Director
-
Salary TBC
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Director Healthcare PR Communications
-
Salary TBC
- Experienced Editor, London, Medical Communications
-
Competitive package
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
Negotiable
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Account Manager, Healthcare Advertising
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Director – Global Healthcare PR
-
Salary TBC
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
Subscribe to our email news alerts
- AcelRX’s potent opioid tablets set to win FDA backing for pain relief
- New leader at Medivir after setbacks
- Roche preps new Kadcyla filings after phase 3 trial win
- Porterhouse Medical Group boosts its scientific services team with two new appointments
- Redefining communications excellence
- AstraZeneca: building a new ‘open innovation’ pharma company
PMHub
Cogora
Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...
Latest intelligence
- Redefining communications excellence
- How to be heard in today’s multichannel, multistakeholder, multimedia world...
- AstraZeneca: building a new ‘open innovation’ pharma company
- The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
- In conversation with Pfizer’s Erik Nordkamp
- Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...
Quick links
Infographics
